Rheumatoid Arthritis (RA) is a chronic, inflammatory autoimmune disease that leads to progressive and destructive polyarthritis and affects approximately 1% of the population. It is characterized by chronic pain and joint destruction that usually progress from distal to more proximal joints. DelveInsight ...
Find MoreThe past decade experienced a lot of shuffling in the Rheumatoid arthritis (RA) market. The journey started with the approvals of disease-modifying anti-rheumatic drugs (DMARDs). Several conventional DMARDs constituting methotrexate, leflunomide, hydroxychloroquine, and sulfasalazine, biologics with initial entrant...
Find MoreBeyond the shadow of a doubt, the Rheumatoid arthritis (RA) treatment market has witnessed strides of improvements during the last few years. There was a time when the treatment for RA was confined to Non-steroidal anti-inflammatory drugs (NSAIDs) and steroids, which could only address pain and swelling. However, t...
Find MoreThe American Society of Clinical Oncology (ASCO) is one of the largest and most respected conferences in the field of oncology. Held annually, this conference brings together researchers, physicians, and other healthcare professionals from around the world to discuss the latest advances in cancer research, diagnosis, and treatment.